FMED · Fidelity Disruptive Medicine ETF
United States · RS rating 82 · As of 2026-10-14
| Price | 30.64 USD |
|---|---|
| 1-day change | +0.5% |
| RS rating (overall / 1M / 3M / 12M) | 82 / 51 / 82 / 73 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 41 / 50 / 42 |
| Industry group (rank) | Finance-ETF / ETN (48) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +6.8% |
| Market cap (USD) | – |